Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

About this update from Sensus Healthcare, Inc.

BOCA RATON, Fla. , Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 14, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Participants are encouraged to pre-register for the conference call using this link . Upon registration participants will receive a unique dial-in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register can access the conference call by dialing 844-481-2811 ( U.S. and Canada Toll Free) or 412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call. The call will be webcast live and can be accessed at this link , which also can be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com . Following the conclusion of the conference call, a telephone replay will be available until December 14, 2024 and can be accessed by dialing 877-344-7529 ( U.S. Toll Free), 855-669-9658 (Canada Toll Free) or 412-317-0088 (International). At the system prompt, enter the replay code 3932512 followed by the # sign. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time. About Sensus Healthcare, Inc. Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com . Contact: Alliance Advisors IR Kim Sutton Golodetz 212-838-3777 [email protected] # # # Source: Sensus Healthcare, Inc.

View stock analysis, news, and events for Sensus Healthcare, Inc.